Table 1 Researcher-identified potential diagnoses (RIPDs) submitted by Clinical Genetics Group, Oxford (CGG) for patients with craniosynostosis (CRS) recruited to the 100,000 Genomes Project (100kGP)a.

From: Evaluating the performance of a clinical genome sequencing program for diagnosis of rare genetic disease, seen through the lens of craniosynostosis

Case

Researcher category (Box 2)

Panels applied in addition to CRS

Gene

cDNA change

Protein change

Tier

Exomiser rank

Inheritance

Gene green on original/updated panel?

Pathogenicity

Also identified by GE/GMC?

Currently identifiable by NHSE pipeline?

Tier 1, 2 or A variants

1

N/A

5

MAN2B1

c.[1830+1G>C];[2248C>T]

p.([?]); ([Arg750Trp])

Tier 1; tier 2

2

Recessive

Original

Pathogenic

Y

Y

2

N/A

10

3.4 Mb Chr 6 del

Tier A

Unranked

De novo

Original

Pathogenic

Y

Y

Monoallelic tier 3 variants

3

N/A

0

KMT5B

c.557T>A

p.(Leu186*)

Tier 3

1

De novo

No

Pathogenic

Y

Y

4

2A

1

SMAD2

c.1223T>C

p.(Leu408Pro)

Tier 3

2

De novo

No

VUS

N/A

N/A

5

2A

0

SMAD6

c.40T>C

p.(Trp14Arg)

Tier 3

1

De novo

Updated

Likely pathogenic

N

Y

6

2A

0

CDK13

c.2563G>C

p.(Asp855His)

Tier 3

2

De novo

No

Likely pathogenic

N

Y

7

2A

7

HNRNPK

c.1291G>T

p.(Glu431*)

Tier 3

1

De novo

Updated

Pathogenic

N

Y

8

2A

1

FBXO11

c.2731_2732insGACA

p.(Thr911Argfs*5)

Tier 3

3

De novo

Updated

Likely pathogenic

N

Y

9

4A

1

SOX6

c.242C>G

p.(Ser81*)

Tier 3

2

De novo

No

Pathogenic

N

Y

10

4C

1

SOX6

c.277C>T

p.(Arg93*)

Tier 3

63

Parents not available

No

Likely Pathogenic

N

N

11

2A

0

BRWD3

c.4012C>T

p.(Gln1338*)

Tier 3

1

De novo

No

Pathogenic

N

Y

12

2A

1

PTCH1

c.290del

p.(Asn97Thrfs*20)

Tier 3

1

De novo

No

Pathogenic

N

Y

13

2A

1

ALX1

c.541C>A

p.(Gln181Lys)

Tier 3

5

De novo

No

VUS

N/A

N/A

Untiered small variants

14

1B; 1B

1

MEGF8

c.[4496G>A];[7766_7768del]

p.([Arg1499His]); ([Phe2589del])

Both untiered

96; unranked

Compound heterozygous

Original

Likely pathogenic/likely pathogenic

N

N

15

1B; 1B

3

MMP21

c.[671_684del];[775C>G]

p.([Val224Glyfs*29]); ([His259Asp])

Untiered; tier 3

Both unranked

Compound heterozygous

Original

Pathogenic/likely pathogenic

N

Y

16

1A

1

ARID1B

c.3594delinsCCCCCA

p.(Gly1199Profs*14)

Untiered

Unranked

De novo

Original

Pathogenic

N

Y

17

2A

1

TRAF7

c.1885A>G

p.(Ser629Gly)

Untiered

3

De novo

Updated

Likely pathogenic

N

Y

18

1E

1

TCF12

c.1870C>T

p.(Leu624Phe)

Untiered

Unranked

De novo

Original

Pathogenic

N

Y

19

N/A

3

OGT

c.539A>G

p.(Tyr180Cys)

Untiered

1

De novo

Updated

Pathogenic

Y

Y

Untiered copy-number and structural variants

20

3D

0

13.4 Mb Chr 7 inv (TWIST1)

Untiered

Unranked

Dominant (proband, affected mother)

Original

Pathogenic

N

N

21

3A

1

314 kb Chr 19 del (ERF)

Untiered

Unranked

De novo (mosaic in unaffected father)

Original

Pathogenic

N

Y

22

3D

2

285 kb Chr 12 dup

Untiered

Unranked

Dominant (mosaic in affected father)

No

Likely pathogenic

N

N

  1. cDNA complementary DNA, GE/GMC Genomics England/Genomic Medicine Centre, N/A not applicable, NHSE NHS England, VUS variant of uncertain significance.
  2. aFor a more detailed version of the content of this table, please see Table S4.